Sublocade treatment basics

What Sublocade is in one sentence

Sublocade is an extended-release formulation of buprenorphine given as a once-monthly subcutaneous injection for the maintenance treatment of moderate-to-severe opioid use disorder in adults, intended to reduce cravings and opioid use by providing sustained medication levels between monthly visits. For product details and patient support resources see the official SUBLOCADE patient resources and the clinical review summary of buprenorphine extended-release, which notes the requirement that patients be stabilised on transmucosal buprenorphine prior to switching SUBLOCADE patient resources, Clinical Review Report: Buprenorphine extended-release injection.

Why Sublocade matters for opioid agonist therapy in Canada

Extended-release buprenorphine like Sublocade is one of the medication options within opioid agonist therapy programs in Canada. National guidance recognises long-acting buprenorphine formulations as tools that can reduce the daily dosing burden and help patients who struggle with daily adherence or medication diversion, provided comprehensive supports are in place Opioid Agonist Treatment guidance, NCBI clinical review. For many people the monthly schedule reduces the need to manage a daily pill or film, and it can simplify adherence for those with unstable housing or limited access to pharmacy services.

Who is eligible and the clinical requirement to start

The central clinical requirement for starting Sublocade is prior induction and clinical stabilisation on a transmucosal buprenorphine-containing product, such as Suboxone, before switching to the monthly injection. This step confirms that buprenorphine therapy is tolerated and effective for the patient NCBI clinical review, SUBLOCADE resources. Sublocade is indicated for adults with moderate-to-severe opioid use disorder. Your prescriber will assess medical history, current medications, liver function where clinically indicated, and any pregnancy considerations before recommending a change in the treatment method.

How Sublocade treatment works and clinic logistics

Sublocade is administered by a trained healthcare provider as a subcutaneous injection to the abdominal area once every month. A typical initiation pathway used in practice involves two steps: first, induction and stabilisation on a transmucosal buprenorphine product; second, a clinic visit for the first Sublocade injection once the prescriber considers the patient clinically stable on transmucosal buprenorphine. During injection visits the clinician will check for injection site condition and ask about cravings, withdrawal, and any side effects. Ongoing monthly visits generally focus on injection administration and clinical monitoring, with more frequent contact if clinical needs arise Sublocade patient tips.

What the first injection visit usually includes

• Verification that you were stabilised on transmucosal buprenorphine and are suitable for the monthly formulation.
• Brief medical assessment and consent discussion, including expected benefits and potential side effects.
• Administration of the injection by a trained clinician and observation for a short period for any immediate reactions.
• Scheduling of follow-up monthly injection appointments and review of who to contact for side effects or missed doses.

How it compares with Suboxone and methadone

Choosing among Sublocade, daily transmucosal buprenorphine (Suboxone), or methadone depends on individual clinical goals, lifestyle, and risks. Below are practical differences to discuss with your prescriber, not universal prescriptions for who should use which treatment.

• Adherence and dosing frequency: Sublocade requires a monthly clinic visit for injection, which can benefit people who find daily dosing difficult. Suboxone requires daily administration, typically managed at home or through pharmacy programs. Methadone usually requires daily pharmacy dosing for many patients, with take-home doses possible over time.
• Risk of diversion: A monthly injectable reduces the risk of medication diversion compared with take-home transmucosal formulations because the medication is not in a portable form.
• Overdose considerations: All opioid agonist therapies reduce the risk of overdose compared with no treatment, but each medication has different interactions with other depressants. Discuss concurrent alcohol or benzodiazepine use with your clinician. For clinical context see the NCBI review on buprenorphine extended-release NCBI clinical review.
• Flexibility: Suboxone allows dose adjustments day to day. Sublocade dosing is set monthly and adjustments require clinic planning. Methadone can be titrated but typically needs closer supervision, especially early in treatment.

Safety, common side effects, and monitoring to discuss

Common side effects reported with Sublocade include injection site reactions, constipation, headache, nausea, and fatigue. Some patients require liver function monitoring if clinically indicated, and any serious adverse symptoms should be reported promptly. Patient-facing resources recommend ongoing adherence to the clinic treatment plan and regular communication with the care team Sublocade patient tips, Sublocade overview and safety, SUBLOCADE resources and FAQs. If you have a history of liver disease, are pregnant, or take other central nervous system depressants, your prescriber will review the risks and monitoring steps with you.

Decision checklist and questions to bring to your first appointment

Use this short yes or no checklist to prepare for a discussion about Sublocade. These prompts are designed to help you and your clinician decide if the monthly injection fits your needs.

• Have you been inducted and clinically stabilised on a transmucosal buprenorphine product such as Suboxone? Yes / No
• Can you attend a clinic once every month for an injection? Yes / No
• Do you have difficulty managing daily medication or concerns about medication diversion? Yes / No
• Do you have active liver disease or take medications that require liver monitoring? Yes / No
• Are you using other substances that depress breathing, such as alcohol or benzodiazepines? Yes / No
• Do you prefer a treatment that reduces the need to carry medication daily? Yes / No

Questions to bring to your prescriber or clinic:

• Am I clinically eligible to switch to Sublocade now, and what would induction look like?
• What monitoring tests will you order, and how often will you see me between injections?
• What should I do if I miss an appointment or a monthly dose?
• How will Sublocade interact with my other medications or health conditions?
• What supports are available if I experience cravings or triggers between injections?
• Can you explain the plan for returning to transmucosal buprenorphine or changing treatment if Sublocade is not a good fit?

How to start Sublocade at Road To Recovery and next steps in Ontario

Road To Recovery lists Sublocade among its offered treatments and provides a same-day intake pathway for new opioid agonist therapy patients, where a nurse triages new patients and a physician sees them on the same day they begin care. Intake is initiated through a secure online portal and psychiatry referrals can be arranged locally or virtually through partners such as CAMH and OTN, supporting integrated care when needed Road To Recovery main site, what sublocade is used for. If you think Sublocade could be right for you, start by completing the clinic intake, bringing this checklist and your current medication list, and asking about the local workflow for induction, stabilisation, and the first injection visit.

Frequently asked questions

Can I start Sublocade without first taking Suboxone or another transmucosal buprenorphine product?

No. Clinical guidance and the product indication require induction and clinical stabilisation on a transmucosal buprenorphine product before initiating Sublocade. This step confirms tolerability and helps the prescriber determine the appropriate timing for the first injection NCBI clinical review, SUBLOCADE resources.

How often will I need to visit the clinic for Sublocade injections and what happens if I miss a monthly dose?

Sublocade is given once a month. If you miss a scheduled monthly dose, contact your clinic promptly to arrange catch-up planning. The clinic will advise on the safest way to re-establish treatment, which may include clinical assessment and consideration of temporary transmucosal buprenorphine until an injectable dose can be administered patient guidance.

What are the most common side effects and what monitoring will my clinician order?

The most common side effects include injection site reactions, nausea, constipation, headache, and fatigue. Clinicians may order liver function tests where clinically indicated and will monitor for signs of opioid withdrawal or unexpected sedation. Discuss your full medical history so your prescriber can tailor monitoring to your needs Sublocade overview and safety, SUBLOCADE resources.

Will Sublocade protect me from overdose and how does it affect other opioids?

Sublocade, like other buprenorphine therapies, can reduce the risk of opioid overdose by stabilising opioid receptors and reducing cravings. However, combining buprenorphine with other sedating substances, such as alcohol or benzodiazepines, increases risk and should be discussed with your clinician. No medication can guarantee full protection against overdose; follow your treatment plan and harm reduction advice from your care team clinical review.

How do I arrange a same-day intake or psychiatry referral at Road To Recovery?

Begin with the Road To Recovery secure intake portal on the clinic website to request an appointment. New OAT intakes are triaged by a nurse and then seen by a physician on the same day they start, and psychiatry referrals can be coordinated through local partners or virtual services like CAMH and OTN when needed Road To Recovery intake and services.

Key takeaway and next step

Sublocade treatment basics mean a once-monthly, clinic-administered buprenorphine option for adults who are already stabilised on transmucosal buprenorphine. It can reduce daily medication management and medication diversion for some patients, but it requires monthly clinic attendance and clinical monitoring. If this seems like a possible fit, use the decision checklist and questions above at your next appointment and begin intake through Road To Recovery’s secure portal to discuss eligibility and the first injection plan what sublocade is used for.

Road To Recovery